Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities

Hepatocellular carcinoma (HCC) accounts for over 80% of liver cancer cases and is highly malignant, recurrent, drug-resistant, and often diagnosed in the advanced stage. It is clear that early diagnosis and a better understanding of molecular mechanisms contributing to HCC progression is clinically...

Descripción completa

Detalles Bibliográficos
Autores principales: De Matteis, Serena, Ragusa, Andrea, Marisi, Giorgia, De Domenico, Stefania, Casadei Gardini, Andrea, Bonafè, Massimiliano, Giudetti, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247426/
https://www.ncbi.nlm.nih.gov/pubmed/30524660
http://dx.doi.org/10.1155/2018/7512159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247426/
https://www.ncbi.nlm.nih.gov/pubmed/30524660
http://dx.doi.org/10.1155/2018/7512159

Ejemplares similares